Drug intelligence / Profile preview

Oscillococcinum

Development stage
Unknown
Lead developer
Boiron
Administration
Oral, Sublingual
01

Overview

Oscillococcinum is a homeopathic preparation manufactured by Boiron Laboratories and marketed for the relief of flu-like symptoms, including body aches, headache, fever, chills, and fatigue. The product's active ingredient is Anas barbariae hepatis et cordis extractum, an extract derived from the heart and liver of the Muscovy duck. This extract is prepared using a 200CK dilution, a process so extreme (1 part in 10^400) that no molecules of the original duck tissue remain in the final sugar-based pellets. As a homeopathic remedy, it follows the principle of 'like cures like,' based on the theory that wildfowl are natural reservoirs for influenza. Oscillococcinum does not have a recognized biological target or conventional mechanism of action. While it has been commercially available for over 80 years in more than 50 countries, independent clinical reviews, such as those by the Cochrane Collaboration, have found no robust evidence that it is more effective than a placebo.

Brand names
Oscillococcinum
Other names
Anas barbariae hepatis et cordis extractum

Beyond the preview

Go deeper on Oscillococcinum.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oscillococcinum.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call